Topical 5% Imiquimod Cream for Vulvar Paget's Disease
Status:
Completed
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety and immunological response of
topical 5% imiquimod cream for non-invasive vulvar Paget's disease.
Phase:
Phase 3
Details
Lead Sponsor:
University Medical Center Nijmegen
Collaborators:
Catharina Ziekenhuis Eindhoven Erasmus Medical Center Leiden University Medical Center The Netherlands Cancer Institute UMC Utrecht University Medical Center Groningen